Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of recombinant human erythropoietin in neonates with hemolytic disease due to red cell alloimmunization
NL-OMON26568Suspended
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of erythropoietin in Erythroblastosis fetalis (HDFN) and anaemia (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Number of top-up transfusions required per infant and Percentage of infants requiring a top-up transfusion. Started Jan 2013; status: suspended.
02
Drugs
erythropoietin
03
Conditions
Erythroblastosis fetalis (HDFN)anaemia
Beyond the preview
Go deeper on NL-OMON26568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26568.